logo ambiotis

The aim of Ambiotis is to advance the care of patients suffering from inflammatory disorders.

Ambiotis is a CRO (Contract Research Organization) offering innovative research services and specialized in testing the anti-inflammatory effect of compounds (therapeutic proteins, cosmetics active molecules, probiotics, …) on various models.

More than 50% of our activity is invested in R&D in order to make our business partners satisfied.

The society develops new human cells or functional models-based protocols in order to investigate the inflammatory process involved in:

 

  • gastrointestinal disorders (Crohn disease, Irritable Bowel Syndrome)
  • smokers’ diseases (Chronic Obstructive Pulmonary Disease)
  • metabolic disorders (Obesity, Atherosclerosis),
  • etc…

Created in 2007, Ambiotis is a Young and Innovative Company. The Incubator Midi-Pyrénées was strongly involved in its start-up support.

 

The company was awarded in 2006-2007 at the National Innovative and Technological Start-Up Competition (organized by the French Ministry of Research) and boosted its growth afterwards.

 

 

 

 
Ambiotis - Incubateur MIPY 29 rue Jeanne Marvig 31400 Toulouse - tél: +33 (0)5 62 24 41 57 - fax: +33 (0)5 61 32 22 93 - contact@ambiotis.com - www.ambiotis.com